⌘K

Home/Filings/4/0000899866-19-000048

4//SEC Filing

ORLOFF JOHN J 4

Accession 0000899866-19-000048

CIK 0000899866other

View on SEC.gov Company Profile

Filed

Mar 4, 7:00 PM ET

Accepted

Mar 5, 8:18 PM ET

Size

4.8 KB

Accession

0000899866-19-000048

Insider Transaction Report

Form 4

Period: 2019-02-28

ALEXION PHARMACEUTICALS, INC.ALXN

EVP, Research & Development

Transactions

Award
Common Stock, par value $.0001 per share
2019-02-28+9,428→ 40,577 total

Footnotes (1)

[F1]Award of Restricted Stock Units under the 2017 Incentive Plan. 25% vests on each anniversary of the grant date.

Documents

1 file

4
wf-form4_155183507279607.xmlPrimary
FORM 4

Issuer

ALEXION PHARMACEUTICALS, INC.

CIK 0000899866

Entity typeother

Related Parties

1

filerCIK 0001643941

Filing Metadata

Form type: 4
Filed: Mar 4, 7:00 PM ET
Accepted: Mar 5, 8:18 PM ET
Size: 4.8 KB

View on SEC.gov